Literature DB >> 4050134

[Distribution of digoxin, digitoxin and their cardioactive metabolites in human heart and kidney tissue. A postmortem study].

J Plum, T Daldrup.   

Abstract

A method was developed for the specific determination of digoxin and digitoxin, as well as their semisynthetic derivatives and dependent cardioactive metabolites, in autopsy samples of heart and kidney. A collective of six patients on long-term treatment with therapeutic doses of beta-acetyldigoxin had a mean myocardial digoxin content of 46.1 +/- 25.0 ng/g (SD); kidney: 50.3 +/- 30.3 ng/g. Digoxigenin bisdigitoxoside represented the second most important metabolite in heart and kidney; digoxigenin monodigitoxoside and digoxigenin follow, respectively. In a collective of seven patients on maintenance treatment with digitoxin, the mean tissue levels were higher but the metabolic pattern was similar (myocardial digitoxin content: 78.9 +/- 38.4 ng/g, renal content: 104.1 +/- 44.1 ng/g). The amount of digoxin formed by hydroxylation under long-term treatment with digitoxin in heart and kidney were approximately 10 ng/g. A case of digoxin intoxication differed both in the tissue content and in the metabolic distribution.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4050134     DOI: 10.1007/BF00205094

Source DB:  PubMed          Journal:  Z Rechtsmed        ISSN: 0044-3433


  26 in total

1.  Correlation of antemortem and postmortem digoxin levels.

Authors:  T E Vorpahl; J I Coe
Journal:  J Forensic Sci       Date:  1978-04       Impact factor: 1.832

2.  Metabolic fate of radioactive digitoxin in human subjects.

Authors:  G T OKITA; P J TALSO; J H CURRY; F D SMITH; E M GEILING
Journal:  J Pharmacol Exp Ther       Date:  1955-12       Impact factor: 4.030

3.  Quantitation of digoxigenin in serum following oral administration of digoxin in humans.

Authors:  J C Loo; I J McGilveray; N Jordan
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-07

4.  Tissue concentrations of digoxin in an autopsy material.

Authors:  J Karjalainen; K Ojala; P Reissell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-05

5.  Correlation of serum concentrations with heart concentrations of digoxin in human subjects.

Authors:  H G Güllner; E B Stinson; D C Harrison; S M Kalman
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

Review 6.  Clinical pharmacology and therapeutics use of digitalis glycosides.

Authors:  J E Doherty; J J Kane
Journal:  Drugs       Date:  1973       Impact factor: 9.546

7.  [Metabolism of digitalis glycosides].

Authors:  A Schmoldt
Journal:  Beitr Gerichtl Med       Date:  1984

8.  Quantitation of digitoxin and the bis- and monodigitoxosides of digitoxigenin in serum.

Authors:  P E Graves; D Perrier; F I Marcus
Journal:  J Chromatogr       Date:  1983-12-09

9.  Digoxin biotransformation.

Authors:  M H Gault; L L Longerich; J C Loo; P T Ko; A Fine; S C Vasdev; M A Dawe
Journal:  Clin Pharmacol Ther       Date:  1984-01       Impact factor: 6.875

10.  [Digoxin concentrations in plasma and tissue. A postmortal investigation (author's transl)].

Authors:  J Weinmann; J Hasford; J Kuhlmann; P H Bippus; J Lichey; N Rietbrock
Journal:  Med Klin       Date:  1979-04-20
View more
  3 in total

1.  Digoxin, magnesium, and potassium levels in a forensic autopsy material of sudden death from ischemic heart disease.

Authors:  A Ottosson; L Edvinsson; A Sjögren; P Löwenhielm
Journal:  Z Rechtsmed       Date:  1988

2.  Measurement of digitalis-glycoside levels in ocular tissues: a way to improve postmortem diagnosis of lethal digitalis-glycoside poisoning? II. Digitoxin.

Authors:  S Ritz; P Harding; W Martz; H W Schütz; H J Kaatsch
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

3.  Measurement of digitalis-glycoside levels in ocular tissues: a way to improve postmortem diagnosis of lethal digitalis-glycoside poisoning? I. Digoxin.

Authors:  S Ritz; P Harding; W Martz; H W Schütz; H J Kaatsch
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.